Core Viewpoint - MIRXES-B (02629) successfully completed a share placement, raising approximately HKD 711 million, with a net amount of about HKD 673 million after costs [1] Group 1: Share Placement Details - The board announced that all conditions for the share placement were met, and the delivery occurred on February 5, 2026 [1] - A total of 21.88 million shares were successfully placed at a price of HKD 32.50 per share [1] - The placement was made to no fewer than six independent subscribers, ensuring that they and their ultimate beneficial owners are independent of the company [1] Group 2: Use of Proceeds - Approximately 30% of the net proceeds will be used for investment and acquisition activities [1] - About 25% will be allocated for research and development, including clinical studies of existing pipelines and development of new pipelines [1] - Approximately 20% will be used to expand into emerging markets [1] - The remaining 25% will be utilized for general working capital purposes [1]
MIRXES-B完成配售合共2188.8万股配售股份，净筹约6.73亿港元